RAISING BRAND DRUG PRICES

Few dispute that the price of brand name drugs is increasing. “Inflation is alive and well in the drug industry,” said Lawrence Marsh, managing director of equity research at Barclays Capital, who tracks drug prices. He said drug companies had been raising prices on drugs whose patent protections were about to end in an effort to squeeze as much profit as they could before losing market share to generics.